79 related articles for article (PubMed ID: 25996239)
1. Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis.
Kuo TH; Lin TH; Yang RS; Kuo SC; Fu WM; Hung HY
J Med Chem; 2015 Jun; 58(12):4954-63. PubMed ID: 25996239
[TBL] [Abstract][Full Text] [Related]
2. Turbo methanol extract inhibits bone resorption through regulation of T cell function.
Balakrishnan B; Indap MM; Singh SP; Krishna CM; Chiplunkar SV
Bone; 2014 Jan; 58():114-25. PubMed ID: 24140785
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
4. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
6. Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.
Hwang YH; Kim KJ; Kim SJ; Mun SK; Hong SG; Son YJ; Yee ST
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562730
[TBL] [Abstract][Full Text] [Related]
7. Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats.
Nanke Y; Kotake S; Ninomiya T; Furuya T; Ozawa H; Kamatani N
Calcif Tissue Int; 2005 Dec; 77(6):376-85. PubMed ID: 16362462
[TBL] [Abstract][Full Text] [Related]
8. D-pinitol inhibits RANKL-induced osteoclastogenesis.
Liu SC; Chuang SM; Tang CH
Int Immunopharmacol; 2012 Mar; 12(3):494-500. PubMed ID: 22269833
[TBL] [Abstract][Full Text] [Related]
9. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
10. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
13. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
Ma X; Liu Y; Zhang Y; Yu X; Wang W; Zhao D
Biochem Biophys Res Commun; 2014 Mar; 445(2):282-8. PubMed ID: 24491533
[TBL] [Abstract][Full Text] [Related]
14. A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase.
Joo JH; Huh JE; Lee JH; Park DR; Lee Y; Lee SG; Choi S; Lee HJ; Song SW; Jeong Y; Goo JI; Choi Y; Baek HK; Yi SS; Park SJ; Lee JE; Ku SK; Lee WJ; Lee KI; Lee SY; Bae YS
Sci Rep; 2016 Mar; 6():22389. PubMed ID: 26975635
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats.
Nian H; Qin LP; Chen WS; Zhang QY; Zheng HC; Wang Y
Acta Pharmacol Sin; 2006 Jun; 27(6):728-34. PubMed ID: 16723092
[TBL] [Abstract][Full Text] [Related]
16. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
17. Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.
Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Kim YS; Lee SK; Chung WY
Fitoterapia; 2012 Dec; 83(8):1523-31. PubMed ID: 22981503
[TBL] [Abstract][Full Text] [Related]
18. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
19. Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro.
Zhang R; Pan YL; Hu SJ; Kong XH; Juan W; Mei QB
J Ethnopharmacol; 2014 Aug; 155(1):104-12. PubMed ID: 24786573
[TBL] [Abstract][Full Text] [Related]
20. Triptolide, a diterpene, inhibits osteoclastogenesis, induced by RANKL signaling and human cancer cells.
Park B
Biochimie; 2014 Oct; 105():129-36. PubMed ID: 25047443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
